SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 16.47 |
Enterprise Value ($M) | 12.40 |
Book Value ($M) | 3.82 |
Book Value / Share | 0.44 |
Price / Book | 4.31 |
NCAV ($M) | 3.82 |
NCAV / Share | 0.44 |
Price / NCAV | 4.31 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.65 |
Return on Assets (ROA) | -2.37 |
Return on Equity (ROE) | -2.54 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.90 |
Current Ratio | 5.90 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 4.60 |
Assets | 4.60 |
Liabilities | 0.78 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Empery Asset Management, LP | 9.99 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
44,711 | 327,451 | 13.65 | |
14,545 | 149,621 | 9.72 | |
41,285 | 131,407 | 31.42 | |
54,909 | 217,056 | 25.30 | |
(click for more detail) |
Similar Companies | |
---|---|
BCDA – BioCardia, Inc. | BCLI – Brainstorm Cell Therapeutics Inc. |
BCTX – BriaCell Therapeutics Corp. | BFRI – Biofrontera Inc. |
BGM – BGM Group Ltd. |
Financial data and stock pages provided by
Fintel.io